|
|
|
1-10 employees
View all Myriad Life Sciences employees
|
|
Venture Capital & Private Equity
|
|
67-11, Nonhyeon-ro 149-gil, Gangnam-gu, Seoul 06039, KR
|
|
Myriad Life Sciences is a strategic advisory and venture accelerator in the life sciences industry, partnering with pioneers in the bio-pharmaceutical industry to accelerate the delivery of innovations and medical breakthroughs.
We combine global expertise and local insights to address the most complex issues that today's healthcare companies face, and scout the globe for therapeutic opportunities those which an infusion of capital and strategic guidance will greatly enhance chances of success.
|
The decision makers in Myriad Life Sciences are Doo-hong Park, Hyungkoo Chung, Mina Lee, etc. Click to Find Myriad Life Sciences decision makers emails.
Myriad Life Sciences offers a comprehensive range of services including genomic testing, precision medicine solutions, and advanced analytics. Their primary focus is on providing insights that help healthcare providers tailor treatments to individual patients, enhancing the effectiveness of therapies in oncology, hereditary cancer, and other genetic conditions.
Myriad Life Sciences supports healthcare providers by delivering actionable genetic information that can guide treatment decisions. Their services include detailed reports on genetic testing results, educational resources for healthcare professionals, and ongoing support to help integrate genetic insights into clinical practice.
Myriad Life Sciences primarily serves the healthcare and pharmaceutical industries. They work closely with hospitals, clinics, and research institutions to provide genetic testing and precision medicine solutions that enhance patient care and support drug development processes.
Yes, Myriad Life Sciences specializes in hereditary cancer testing. They offer a variety of genetic tests that assess an individual's risk for certain hereditary cancers, such as breast, ovarian, and colorectal cancer. Their tests are designed to identify mutations in genes that are known to increase cancer risk, enabling proactive management and personalized treatment options.
To obtain genetic testing through Myriad Life Sciences, patients typically start by consulting with their healthcare provider, who can determine if genetic testing is appropriate. Once a test is ordered, a sample is collected (usually through a blood or saliva sample), and it is sent to Myriad's laboratory for analysis. Results are then provided to the healthcare provider, who will discuss the findings and implications with the patient.
Myriad Life Sciences employs rigorous quality control measures and adheres to strict regulatory standards to ensure the accuracy and reliability of its genetic tests. Their laboratories are CLIA-certified and CAP-accredited, meaning they meet high standards for laboratory testing. Additionally, they utilize advanced technologies and methodologies to analyze genetic data, ensuring precise results for patients and healthcare providers.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.